Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1977;55:388-394

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giardina, E-G.
Right arrow Articles by Bigger, J. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giardina, E-G.
Right arrow Articles by Bigger, J. T.

Circulation, Vol 55, 388-394, Copyright © 1977 by American Heart Association


ARTICLES

The relationship between the metabolism of procainamide and sulfamethazine

E-GV Giardina, RM Stein and JT Bigger

The metabolism of sulfamethazine (SMZ), which is acetylated by a binodally distributed enzyme, and procainamide (PA) was compared in 21 normal volunteers, each given a single oral dosted metabolites, N- acetyl-procainamide (NAPA) and Ac-SMZ, were measured. Subjects with less than 64% Ac-SMZ in the 0-8 hour collection were termed "slow" and those with more than 64% were termed "fast" SMZ acetylators. Slow SMZ acetylators had 9.8 to 43.8% (24.1 +/- 10.13) NAPA recovered, and fast SMZ acetylators, 22.0 to 42.6% (33.7 +/- 7.29) NAPA, P less than 0.01. In addition, the calculated half-life of PA metabolism for slow SMZ acetylators was 9.0 to 33.8 hours (18.4 +/- 8.82) and for fast SMZ acetylators was 8.1 to 14.4 hours (10.9 +/- 2.19), P less than 0.01. For four subjects, SMZ acetylation phenotype did not correlate with the half-life of SMZ or PA metabolism; and in two, SMZ acetylation phenotype and half-life of metabolism did not correlate with the same PA indices. Even though slow SMZ acetylators have less NAPA recovered than fast SMZ acetylators, it is not yet clear that procainamide is metabolized by a bimodally distributed enzyme as is sulfamethazine.


This article has been cited by other articles:


Home page
Journal of Pharmacy PracticeHome page
R. J. Straka and P. S. Marshall
The Clinical Significance of the Pharmacogenetics of Cardiovascular Medications
Journal of Pharmacy Practice, January 1, 1992; 5(6): 337 - 361.
[Abstract] [PDF]